156 related articles for article (PubMed ID: 3986078)
1. Pharmacokinetics of metronidazole in patients with varying degrees of renal failure.
Houghton GW; Dennis MJ; Gabriel R
Br J Clin Pharmacol; 1985 Feb; 19(2):203-9. PubMed ID: 3986078
[TBL] [Abstract][Full Text] [Related]
2. Metronidazole pharmacokinetics in patients with acute renal failure.
Somogyi AA; Kong CB; Gurr FW; Sabto J; Spicer WJ; McLean AJ
J Antimicrob Chemother; 1984 Feb; 13(2):183-9. PubMed ID: 6706889
[TBL] [Abstract][Full Text] [Related]
3. Disposition and metabolism of metronidazole in patients with liver failure.
Farrell G; Baird-Lambert J; Cvejic M; Buchanan N
Hepatology; 1984; 4(4):722-6. PubMed ID: 6745863
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of metronidazole and its metabolites in reduced renal function.
Bergan T; Thorsteinsson SB
Chemotherapy; 1986; 32(4):305-18. PubMed ID: 3731917
[TBL] [Abstract][Full Text] [Related]
5. Metronidazole: pharmacokinetic observations in severely ill patients.
Ljungberg B; Nilsson-Ehle I; Ursing B
J Antimicrob Chemother; 1984 Sep; 14(3):275-83. PubMed ID: 6490572
[TBL] [Abstract][Full Text] [Related]
6. Metronidazole kinetics in dialysis patients.
Kreeft JH; Ogilvie RI; Dufresne LR
Surgery; 1983 Jan; 93(1 Pt 2):149-53. PubMed ID: 6849199
[TBL] [Abstract][Full Text] [Related]
7. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A
Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541
[TBL] [Abstract][Full Text] [Related]
8. Disposition and removal of metronidazole in patients undergoing haemodialysis.
Somogyi A; Kong C; Sabto J; Gurr FW; Spicer WJ; McLean AJ
Eur J Clin Pharmacol; 1983; 25(5):683-7. PubMed ID: 6662167
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
Lamp KC; Freeman CD; Klutman NE; Lacy MK
Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
[TBL] [Abstract][Full Text] [Related]
10. Single- and multiple-dose pharmacokinetics, kidney tolerability and plasma protein binding of tenoxicam in renally impaired patients and healthy volunteers.
Nilsen OG; Aasarød K; Widerøe TE; Guentert TW
Pharmacol Toxicol; 2001 Nov; 89(5):265-72. PubMed ID: 11881981
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of temocillin in patients with normal and impaired renal function.
Boelaert J; Daneels R; Schurgers M; Lambert AM; Van Landuyt HW; Mellows G; Wolf J; Swaisland AJ
J Antimicrob Chemother; 1983 Apr; 11(4):349-56. PubMed ID: 6853404
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.
Lau AH; Lam NP; Piscitelli SC; Wilkes L; Danziger LH
Clin Pharmacokinet; 1992 Nov; 23(5):328-64. PubMed ID: 1478003
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.
Kleinbloesem CH; van Brummelen P; van Harten J; Danhof M; Breimer DD
Clin Pharmacol Ther; 1985 May; 37(5):563-74. PubMed ID: 3987180
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of metronidazole in hospitalized patients.
Lau A
Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):643-5. PubMed ID: 3818143
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of vinpocetine and apovincaminic acid in patients with impaired renal function.
Miskolczi P; Vereczkey L; Szalay L; Göndöcs CS
Eur J Drug Metab Pharmacokinet; 1984; 9(2):169-75. PubMed ID: 6745306
[TBL] [Abstract][Full Text] [Related]
17. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.
Frimodt-Möller N; Maigaard S; Toothaker RD; Bundtzen RW; Brodey MV; Craig WA; Welling PG; Madsen PO
Antimicrob Agents Chemother; 1980 Apr; 17(4):599-607. PubMed ID: 6446877
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of naproxen in subjects with normal and impaired renal function.
Anttila M; Haataja M; Kasanen A
Eur J Clin Pharmacol; 1980 Oct; 18(3):263-8. PubMed ID: 7439246
[TBL] [Abstract][Full Text] [Related]
19. Influence of dose and route of administration on disposition of metronidazole and its major metabolites.
Loft S; Døssing M; Poulsen HE; Sonne J; Olesen KL; Simonsen K; Andreasen PB
Eur J Clin Pharmacol; 1986; 30(4):467-73. PubMed ID: 3743624
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of carteolol in relation to renal function.
Hasenfuss G; Schäfer-Korting M; Knauf H; Mutschler E; Just H
Eur J Clin Pharmacol; 1985; 29(4):461-5. PubMed ID: 4092726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
